These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1678906)

  • 1. Comment: parenteral H2-receptor antagonist intervention.
    Glazier HS
    DICP; 1991 Jun; 25(6):681-2. PubMed ID: 1678906
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of direct pharmacist intervention on conversion from parenteral to oral histamine H2-receptor antagonist therapy.
    Kirking DM; Svinte MK; Berardi RR; Cornish LA; Chaffee BW; Ryan ML
    DICP; 1991 Jan; 25(1):80-4. PubMed ID: 1672572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of histamine (H2)-receptor antagonists in total parenteral nutrition patients.
    Baptista RJ
    Am J Med; 1987 Dec; 83(6A):53-7. PubMed ID: 2892408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving perspectives on parenteral H2-receptor antagonist therapy.
    Peura DA; Freston JW
    Am J Med; 1987 Dec; 83(6A):1-2. PubMed ID: 2892403
    [No Abstract]   [Full Text] [Related]  

  • 5. Considerations for selection of parenteral histamine (H2)-receptor antagonists.
    Wolfe MM
    Am J Med; 1987 Dec; 83(6A):82-8. PubMed ID: 2892411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.
    Kett K; Aadland E; Berstad A
    Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for the use of parenteral H2-receptor antagonists.
    Thompson JC; Walker JP
    Am J Med; 1984 Nov; 77(5B):111-5. PubMed ID: 6150638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical review of continuous infusion H2 receptor therapy.
    Rovers JP; Souney PF
    Crit Care Med; 1989 Aug; 17(8):814-21. PubMed ID: 2568898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influencing parenteral histamine2-receptor antagonist use.
    Sesin GP; Provost PS; O'Keefe EM
    DICP; 1989 Oct; 23(10):812. PubMed ID: 2573203
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-use review program for concurrent histamine H2-receptor antagonist-sucralfate therapy.
    Kane MP; Briceland LL; Garris RE; Favreau BN
    Am J Hosp Pharm; 1990 Sep; 47(9):2007-10. PubMed ID: 1977317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving perspectives on parenteral H2-receptor antagonist therapy. Symposium. Tucson, Arizona, April l0-11, 1987.
    Am J Med; 1987 Dec; 83(6A):1-88. PubMed ID: 2892404
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety perspectives on parenteral H2-receptor antagonists.
    Freston JW
    Am J Med; 1987 Dec; 83(6A):58-67. PubMed ID: 2892409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroduodenal rebleeding on cimetidine.
    Dudley HA; Fielding LP; Glazer G
    Lancet; 1977 Feb; 1(8009):481. PubMed ID: 65581
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of parenteral histamine (H2)-antagonists in acid suppression for the prevention of stress ulceration.
    Critchlow JF
    Am J Med; 1987 Dec; 83(6A):23-8. PubMed ID: 2892406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cimetidine and ranitidine on mucosal potential difference.
    von Kleist D; Stopik D; Hampel KE
    Lancet; 1979 Nov; 2(8151):1071-2. PubMed ID: 91804
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment: change in prescribing patterns of intravenous histamine2-receptor antagonists.
    Jay GT; Quercia RA
    Ann Pharmacother; 1993 Nov; 27(11):1406-7. PubMed ID: 7904490
    [No Abstract]   [Full Text] [Related]  

  • 18. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    Lin TM; Evans DC; Warrick MW; Pioch RP
    J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.
    Burland WL; Duncan WA; Hesselbo T; Mills JG; Sharpe PC; Haggie SJ; Wyllie JH
    Br J Clin Pharmacol; 1975 Dec; 2(6):481-6. PubMed ID: 9952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers.
    Okabe S; Takeuchi K; Urushidani T; Takagi K
    Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.